This Article Full Text Full Text (PDF) All Versions of this Article: 146/3/1328    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tremblay, F. Articles by Marette, A. Search for Related Content PubMed PubMed Citation Articles by Tremblay, F. Articles by Marette, A.

Activation of the Mammalian Target of Rapamycin Pathway Acutely Inhibits Insulin Signaling to Akt and Glucose Transport in 3T3-L1 and Human Adipocytes

Department of Anatomy and Physiology and Lipid Research Unit (F.T., A.V., A.M.), Laval University Hospital Research Center, Ste-Foy, Québec, Canada G1V 4G2; and Departments of Medicine and Biochemistry, Microbiology and Immunology (A.G., A.S.), University of Ottawa, Ottawa Health Research Institute, Ottawa, Ontario, Canada K1Y 4E9

Address all correspondence and requests for reprints to: André Marette, Ph.D., Department of Anatomy and Physiology and Lipid Research Unit, Laval University Hospital Research Center, 2705 Laurier Boulevard, Ste-Foy, Québec, Canada G1V 4G2. E-mail: andre.marette{at}crchul.ulaval.ca.

The mammalian target of rapamycin (mTOR) pathway has recently emerged as a chronic modulator of insulin-mediated glucose metabolism. In this study, we evaluated the involvement of this pathway in the acute regulation of insulin action in both 3T3-L1 and human adipocytes. Insulin rapidly (t_1/2 = 5 min) stimulated the mTOR pathway, as reflected by a 10-fold stimulation of 70-kDa ribosomal S6 kinase 1 (S6K1) activity in 3T3-L1 adipocytes. Inhibition of mTOR/S6K1 by rapamycin increased insulin-stimulated glucose transport by as much as 45% in 3T3-L1 adipocytes. Activation of mTOR/S6K1 by insulin was associated with a rapamycin-sensitive increase in Ser636/639 phosphorylation of insulin receptor substrate (IRS)-1 but, surprisingly, did not result in impaired IRS-1-associated phosphatidylinositol (PI) 3-kinase activity. However, insulin-induced activation of Akt was increased by rapamycin. Insulin also activated S6K1 and increased phosphorylation of IRS-1 on Ser636/639 in human adipocytes. As in murine cells, rapamycin treatment of human adipocytes inhibited S6K1, blunted Ser636/639 phosphorylation of IRS-1, leading to increased Akt activation and glucose uptake by insulin. Further studies in 3T3-L1 adipocytes revealed that rapamycin prevented the relocalization of IRS-1 from the low-density membranes to the cytosol in response to insulin. Furthermore, inhibition of mTOR markedly potentiated the ability of insulin to increase PI 3,4,5-triphosphate levels concomitantly with an increased phosphorylation of Akt at the plasma membrane, low-density membranes, and cytosol. However, neither GLUT4 nor GLUT1 translocation induced by insulin were increased by rapamycin treatment. Taken together, these results indicate that the mTOR pathway is an important modulator of the signals involved in the acute regulation of insulin-stimulated glucose transport in 3T3-L1 and human adipocytes.

This article has been cited by other articles:

				K. A. Robinson and M. G. Buse Mechanisms of high-glucose/insulin-mediated desensitization of acute insulin-stimulated glucose transport and Akt activation Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E870 - E881. [Abstract] [Full Text] [PDF]

				X. Yang, C. Yang, A. Farberman, T. C. Rideout, C. F. M. de Lange, J. France, and M. Z. Fan The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth J Anim Sci, April 1, 2008; 86(14_suppl): E36 - E50. [Abstract] [Full Text] [PDF]

				J.-H. Kim, J. E. Kim, H.-Y. Liu, W. Cao, and J. Chen Regulation of Interleukin-6-induced Hepatic Insulin Resistance by Mammalian Target of Rapamycin through the STAT3-SOCS3 Pathway J. Biol. Chem., January 11, 2008; 283(2): 708 - 715. [Abstract] [Full Text] [PDF]

				V. Meske, F. Albert, and T. G. Ohm Coupling of Mammalian Target of Rapamycin with Phosphoinositide 3-Kinase Signaling Pathway Regulates Protein Phosphatase 2A- and Glycogen Synthase Kinase-3 -dependent Phosphorylation of Tau J. Biol. Chem., January 4, 2008; 283(1): 100 - 109. [Abstract] [Full Text] [PDF]

				J. Tamburini, N. Chapuis, V. Bardet, S. Park, P. Sujobert, L. Willems, N. Ifrah, F. Dreyfus, P. Mayeux, C. Lacombe, et al. Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways Blood, January 1, 2008; 111(1): 379 - 382. [Abstract] [Full Text] [PDF]

				M. Garcia-San Frutos, T. Fernandez-Agullo, A. J. De Solis, A. Andres, C. Arribas, J. M. Carrascosa, and M. Ros Impaired Central Insulin Response in Aged Wistar Rats: Role of Adiposity Endocrinology, November 1, 2007; 148(11): 5238 - 5247. [Abstract] [Full Text] [PDF]

				S. C. Ruffolo, P. K. A. Forsell, X. Yuan, S. Desmarais, J. Himms-Hagen, W. Cromlish, K. K. Wong, and B. P. Kennedy Basal Activation of p70S6K Results in Adipose-specific Insulin Resistance in Protein-tyrosine Phosphatase 1B / Mice J. Biol. Chem., October 19, 2007; 282(42): 30423 - 30433. [Abstract] [Full Text] [PDF]

				F. Tremblay, S. Brule, S. Hee Um, Y. Li, K. Masuda, M. Roden, X. J. Sun, M. Krebs, R. D. Polakiewicz, G. Thomas, et al. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance PNAS, August 28, 2007; 104(35): 14056 - 14061. [Abstract] [Full Text] [PDF]

				A. Tzatsos and P. N. Tsichlis Energy Depletion Inhibits Phosphatidylinositol 3-Kinase/Akt Signaling and Induces Apoptosis via AMP-activated Protein Kinase-dependent Phosphorylation of IRS-1 at Ser-794 J. Biol. Chem., June 22, 2007; 282(25): 18069 - 18082. [Abstract] [Full Text] [PDF]

				H. L. Wieman, J. A. Wofford, and J. C. Rathmell Cytokine Stimulation Promotes Glucose Uptake via Phosphatidylinositol-3 Kinase/Akt Regulation of Glut1 Activity and Trafficking Mol. Biol. Cell, April 1, 2007; 18(4): 1437 - 1446. [Abstract] [Full Text] [PDF]

				V. van Harmelen, M. Ryden, E. Sjolin, and J. Hoffstedt A role of lipin in human obesity and insulin resistance: relation to adipocyte glucose transport and GLUT4 expression J. Lipid Res., January 1, 2007; 48(1): 201 - 206. [Abstract] [Full Text] [PDF]

				K. Morino, K. F. Petersen, and G. I. Shulman Molecular Mechanisms of Insulin Resistance in Humans and Their Potential Links With Mitochondrial Dysfunction Diabetes, December 1, 2006; 55(Supplement_2): S9 - S15. [Abstract] [Full Text] [PDF]

				O. J. Shah and T. Hunter Turnover of the Active Fraction of IRS1 Involves Raptor-mTOR- and S6K1-Dependent Serine Phosphorylation in Cell Culture Models of Tuberous Sclerosis. Mol. Cell. Biol., September 1, 2006; 26(17): 6425 - 6434. [Abstract] [Full Text] [PDF]

				B. Draznin Molecular Mechanisms of Insulin Resistance: Serine Phosphorylation of Insulin Receptor Substrate-1 and Increased Expression of p85{alpha}: The Two Sides of a Coin. Diabetes, August 1, 2006; 55(8): 2392 - 2397. [Abstract] [Full Text] [PDF]

				S. Di Paolo, A. Teutonico, D. Leogrande, C. Capobianco, and P. F. Schena Chronic Inhibition of Mammalian Target of Rapamycin Signaling Downregulates Insulin Receptor Substrates 1 and 2 and AKT Activation: A Crossroad between Cancer and Diabetes? J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2236 - 2244. [Abstract] [Full Text] [PDF]

				A. Tzatsos and K. V. Kandror Nutrients Suppress Phosphatidylinositol 3-Kinase/Akt Signaling via Raptor-Dependent mTOR-Mediated Insulin Receptor Substrate 1 Phosphorylation Mol. Cell. Biol., January 1, 2006; 26(1): 63 - 76. [Abstract] [Full Text] [PDF]

				R. C. Hresko and M. Mueckler mTOR{middle dot}RICTOR Is the Ser473 Kinase for Akt/Protein Kinase B in 3T3-L1 Adipocytes J. Biol. Chem., December 9, 2005; 280(49): 40406 - 40416. [Abstract] [Full Text] [PDF]

				A. Danielsson, A. Ost, F. H. Nystrom, and P. Stralfors Attenuation of Insulin-stimulated Insulin Receptor Substrate-1 Serine 307 Phosphorylation in Insulin Resistance of Type 2 Diabetes J. Biol. Chem., October 14, 2005; 280(41): 34389 - 34392. [Abstract] [Full Text] [PDF]

				S.-Y. Li, C. X Fang, N. S Aberle II, B. H Ren, A. F Ceylan-Isik, and J. Ren Inhibition of PI-3 kinase/Akt/mTOR, but not calcineurin signaling, reverses insulin-like growth factor I-induced protection against glucose toxicity in cardiomyocyte contractile function J. Endocrinol., September 1, 2005; 186(3): 491 - 503. [Abstract] [Full Text] [PDF]

				S.-Y. Sun, L. M. Rosenberg, X. Wang, Z. Zhou, P. Yue, H. Fu, and F. R. Khuri Activation of Akt and eIF4E Survival Pathways by Rapamycin-Mediated Mammalian Target of Rapamycin Inhibition Cancer Res., August 15, 2005; 65(16): 7052 - 7058. [Abstract] [Full Text] [PDF]